Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF): A Type 1 Hybrid Effectiveness- Implementation Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is trying to improve the hospital-to-home transition for people with heart failure who receive home care services. The study will test an intervention called I-TRANSFER-HF, which differs from usual care by combining early home health nurse visits and outpatient medical appointments. The study is interested in two questions: 1. Is I-TRANSFER-HF better than usual care at preventing heart failure patients from returning to the hospital within 30 days? 2. Are there parts of I-TRANSFER-HF that are easy or hard to implement in the real world? The researchers will answer these questions by testing the intervention among pairs of hospitals and home health agencies across the country. During the study, the hospital-agency pairs will be asked to implement I-TRANSFER-HF. The researchers will then compare the results from before and after I-TRANSFER-HF was adopted. They will also interview people from these hospitals and agencies to see how I-TRANSFER-HF is being implemented under real-world conditions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Adults hospitalized for HF who transition from participating hospitals to their partner HHC agency during the study period.

⁃ \- Healthcare professional involved in the transition of heart failure patients from the acute care setting (hospital) to HHC (home health care) agencies, and the implementation of the I-TRANSFER-HF at one of the four participating hospital-HHC dyads.

Locations
United States
New York
VNS Health Partners in Care
RECRUITING
New York
Weill Cornell Medicine
RECRUITING
New York
Contact Information
Primary
Madeline R Sterling, MD, MPH, MS
mrs9012@med.cornell.edu
6469625029
Time Frame
Start Date: 2026-07-01
Estimated Completion Date: 2028-07-01
Participants
Target number of participants: 1094
Treatments
Experimental: I-TRANSFER-HF
This is a 1-year long intervention period when I-TRANSFER-HF is in operation.
No_intervention: Standard of Care (usual care)
This is a baseline period of usual care (UC) with no intervention.
Related Therapeutic Areas
Sponsors
Collaborators: NYU Langone Health, University of California, San Diego, Johns Hopkins University, University of Colorado, Denver, National Heart, Lung, and Blood Institute (NHLBI)
Leads: Weill Medical College of Cornell University

This content was sourced from clinicaltrials.gov